Nuren Medical and Research Center | Miami, FL

Research site

Location

8260 West Flagler Street, Suite 2N, Miami, Florida, United States of America

Site insights

Top conditions

Top treatments

Lansoprazole

Vibegron

Ontamalimab

Bococizumab

Vonoprazan

apixaban

EDP-235

Lunsekimig

Obeldesivir

Nadolol

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Humberto Hernandez

Verified by this site

Active trials

3 of 19 total trials

A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease

The main purpose of this study is to investigate the antiviral effect of S-337395 compared with placebo among nonhospitalized adult participants with...

Enrolling

Respiratory Syncytial Virus Infections

Drug: Placebo

Drug: S-337395

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a...

Enrolling

COVID-19

SARS-COV-2 Infection

Biological: Placebo

Biological: BNT162b2 Vaccine

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype (PERSEPHONE)

This is a parallel, Phase 2/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig...

Enrolling

Chronic Obstructive Pulmonary Disease

Drug: Placebo

Drug: Lunsekimig